Online citations, reference lists, and bibliographies.
← Back to Search

Treatment Of Intervention Sites Of Malignant Pleural Mesothelioma With Radiotherapy: A Dutch-Belgian Survey.

D. D. De Ruysscher, B. Slotman
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
A survey was performed on the radiotherapy practice of malignant pleural mesothelioma in The Netherlands and Belgium in 2002. Thirty-eight out of 47 centres (81%) responded. Prophylactic radiotherapy to intervention sites is given by 32/38 (84%) centres, with all centres offering palliative radiation. For both prophylactic and palliative indications, all centres use hypo-fractionated schedules. The present study shows that in the radiotherapy community in The Netherlands and in Belgium, a de facto consensus exists that both prophylactic and symptomatic radiotherapy to intervention sites of malignant pleural mesothelioma are effective and that hypo-fractionated schedules should be used.
This paper references
10.1200/JCO.1999.17.1.25
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
M. Byrne (1999)
10.1067/MTC.2001.111176
The α folate receptor is highly activated in malignant pleural mesothelioma
R. Bueno (2001)
10.1016/S0954-6111(96)90286-3
Methods to improve the diagnostic accuracy of malignant mesothelioma.
A. Dejmek (1996)
10.1097/00008469-199908000-00007
Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study.
M. Janssen-Heijnen (1999)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/S0936-6555(05)80540-0
Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy.
E. Low (1995)
10.1200/JCO.1994.12.6.1156
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1016/S0169-5002(00)80568-1
Radiotherapy to mesothelioma drain sites may not be worthwhile — Interim report of a randomised study
N. O'Rourkee (2000)
10.1378/CHEST.108.3.754
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
C. Boutin (1995)



This paper is referenced by
10.1016/j.lungcan.2018.10.009
Real-life treatment practice for malignant pleural mesothelioma in Belgium.
M. Rosskamp (2018)
Explorer What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma ?
A. Price (2017)
10.5772/55722
Malignant Pleural Mesothelioma and the Role of Non– Operative Therapies
K. Lau (2013)
10.1016/J.RADONC.2007.05.022
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.
N. O’Rourke (2007)
10.3978/j.issn.2072-1439.2013.11.28
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
N. van Zandwijk (2013)
10.1016/j.ijrobp.2009.06.037
Radiotherapy in malignant pleural mesothelioma.
M. McAleer (2009)
10.1158/0008-5472.CAN-06-2877
Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution.
T. Udagawa (2007)
10.1016/J.RADION.2003.11.005
Survey on the prophylactic as well as symptomatic treatment of intervention sites of malignant pleural mesothelioma in the Netherlands and Belgium.
J. van der Zee (2004)
10.1016/j.rpor.2012.07.015
Radiotherapy applications of patients with malignant mesothelioma: A single center experience.
M. Akmansu (2012)
10.1634/theoncologist.2010-0185
What is the role of radiotherapy in malignant pleural mesothelioma?
A. Price (2011)
10.1002/14651858.CD012541
Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma
Jacques Eastment (2017)
10.1016/J.ARBRES.2014.06.005
Diagnóstico y tratamiento del mesotelioma pleural maligno
Francisco Rodríguez Panadero (2015)
10.1016/j.critrevonc.2016.05.004
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
10.1016/j.arbres.2014.06.005
Diagnosis and treatment of malignant pleural mesothelioma.
F. Rodríguez Panadero (2015)
10.1016/J.RMCLC.2015.04.020
ASPECTOS DIAGNÓSTICOS Y TERAPÉUTICOS EN EL MESOTELIOMA PLEURAL MALIGNO
Pinto Rodríguez (2015)
10.1136/bmjopen-2014-006673
Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases
A. Clive (2015)
10.1007/978-3-319-28761-4_20
Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma
Gokhan Ozyigit (2016)
10.1016/J.CLON.2006.12.006
The role of radiotherapy in the treatment of malignant pleural mesothelioma.
K. Waite (2007)
10.1016/J.ARBR.2015.02.009
Diagnosis and Treatment of Malignant Pleural Mesothelioma
F. R. Panadero (2015)
10.1016/J.BRACHY.2004.11.003
A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma.
K. Rosenzweig (2005)
10.1097/MCP.0b013e3282fcea50
Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues
H. E. Davies (2008)
10.1080/02841860701754182
Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma
M. Di Salvo (2008)
10.1016/j.lungcan.2007.12.022
Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma.
M. Metintas (2008)
10.1586/era.10.169
Malignant pleural mesothelioma: when is radiation therapy indicated?
Eric RE van Thiel (2011)
10.1097/COC.0b013e3181d31f02
Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma
C. Pinto (2011)
10.1007/s00270-017-1583-7
A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma
B. Welch (2017)
10.1016/S1470-2045(16)30095-X
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
A. Clive (2016)
10.1007/174_2017_27
Lung Cancer and Other Thoracic Malignancies
M. Harkenrider (2017)
10.1016/j.ctrv.2012.11.004
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations.
C. Pinto (2013)
10.1016/j.lungcan.2015.05.014
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
R. Damhuis (2015)
Malignant Pleural Mesothelioma and the Role of Non – Operative Therapies Kelvin
C. Ng (2018)
Semantic Scholar Logo Some data provided by SemanticScholar